Cargando…
Use of Favipiravir for the Treatment of Coronavirus Disease 2019 in the Setting of Hospitel
OBJECTIVE: In a setting with a limited capacity for hospitalization, “hospitels” have been developed by using hotels as extension healthcare facilities for patients with mild illness. This study examined the clinical evidence of patients with coronavirus disease 2019 (COVID-19) who were treated with...
Autores principales: | Surapat, Bhitta, Kobpetchyok, Warissa, Kiertiburanakul, Sasisopin, Arnuntasupakul, Vanlapa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9159170/ https://www.ncbi.nlm.nih.gov/pubmed/35685498 http://dx.doi.org/10.1155/2022/3098527 |
Ejemplares similares
-
Clinical Course and Outcomes among COVID-19 Patients at the Hospitel in Bangkok: A Retrospective Study
por: Bruminhent, Jackrapong, et al.
Publicado: (2022) -
Microbial epidemiology and risk factors for relapse in gram-negative bacteria catheter-related bloodstream infection with a pilot prospective study in patients with catheter removal receiving short-duration of antibiotic therapy
por: Surapat, Bhitta, et al.
Publicado: (2020) -
Acute Gouty Arthritis During Favipiravir Treatment for Coronavirus Disease 2019
por: Hase, Ryota, et al.
Publicado: (2020) -
Clinical characteristics and risk factors for coronavirus disease 2019 (COVID-19) among patients under investigation in Thailand
por: Bruminhent, Jackrapong, et al.
Publicado: (2020) -
Favipiravir-induced Liver Injury in Patients with Coronavirus Disease 2019
por: Kumar, Pramod, et al.
Publicado: (2021)